Delivery Order SPE2DB22D3501-SPE2DB24FVW02

Award Date 6/3/24
Potential Completion Date 6/4/24
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lupron Depot 11.25 mg 3-month kits. The contract has a ceiling value of $79,635.18 and is a firm fixed-price delivery order that runs through September 15, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,184.12 firm fixed-price delivery order is for the supply of Lupron Depot 11.25 mg 3-month kits, a specialty medication used for various medical treatments. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $15,298.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lupron Depot 11.25 mg 3-month kits, a specialty medication. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as Amerisourcebergen, with the DLA Troop Support Medical....
This federal contract award, valued at $38,110.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lupron Depot 11.25 mg 3-month kits, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, worth up to $999,999,999 and running through November 2026. This IDC serves...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $18,704.53 firm-fixed-price delivery order is for the supply of Lupron Depot 11.25 mg 3-month injection kits. The award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the agency to efficiently procure a...
This federal contract award is for the delivery of Lupron Depot 11.25 mg 3-month kits to the Defense Logistics Agency (DLA). The contract, valued at $20,772.48, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of LUPRON DEPOT 11.25 MG 3MO KITS to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, for a total ceiling value of $4,702.61. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is June 13, 2024....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,768.69 firm fixed-price delivery order is for the supply of Lupron Depot 11.25 mg 3-month kits, a specialty medication. The contract has an ultimate completion date of November 1, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide LUPRON DEPOT 11.25 MG 3MO KITS. The firm-fixed-price delivery order has a ceiling value of $2,111.16 and an ultimate completion date of August 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Lupron Depot 11.25 mg 3-month kits, a specialty medication, with a ceiling value of $29,929.27. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 12, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FVW02
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Lupron Depot 11.25 mg 3-month kits. The contract has a ceiling value of $7,146.20 and is a firm fixed-price delivery order that runs through June 4, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award was not set aside for any specific business category.

Generated 9/2/24, 3:29 PM